{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T08:45:22Z","timestamp":1777020322091,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Geriatr Med"],"DOI":"10.1007\/s41999-025-01399-2","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:40:02Z","timestamp":1767706802000},"page":"941-949","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Time to remission and steroid doses in older and younger patients with polymyalgia rheumatica"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3052-609X","authenticated-orcid":false,"given":"Sibel","family":"\u00d6sken","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Engin","family":"Tezcan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"issue":"10","key":"1399_CR1","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1136\/annrheumdis-2015-207492","volume":"74","author":"C Dejaco","year":"2015","unstructured":"Dejaco C, Singh YP, Perel P et al (2015) European League Against Rheumatism; American College of Rheumatology. 2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative. Ann Rheum Dis 74(10):1799\u20131807. https:\/\/doi.org\/10.1136\/annrheumdis-2015-207492","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1399_CR2","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2023.12242","volume":"26","author":"MM Florescu","year":"2023","unstructured":"Florescu MM, Bobirc\u0103 F, Florescu A et al (2023) Polymyalgia rheumatica: an update (review). Exp Ther Med 26(6):543. https:\/\/doi.org\/10.3892\/etm.2023.12242","journal-title":"Exp Ther Med"},{"issue":"5","key":"1399_CR3","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1080\/030097401753180327","volume":"30","author":"G Myklebust","year":"2001","unstructured":"Myklebust G, Gran JT (2001) Prednisolone maintenance dose in relation to starting dose in the treatment of polymyalgia rheumatica and temporal arteritis. A prospective two-year study in 273 patients. Scand J Rheumatol 30(5):260\u2013267. https:\/\/doi.org\/10.1080\/030097401753180327","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"1399_CR4","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1093\/gerona\/glu057","volume":"69","author":"C Franceschi","year":"2014","unstructured":"Franceschi C, Campisi J (2014) Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci 69(1):S4-9. https:\/\/doi.org\/10.1093\/gerona\/glu057","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"8","key":"1399_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-020-00919-2","volume":"22","author":"T Gazitt","year":"2020","unstructured":"Gazitt T, Zisman D, Gardner G (2020) Polymyalgia rheumatica: a common disease in seniors. Curr Rheumatol Rep 22(8):40. https:\/\/doi.org\/10.1007\/s11926-020-00919-2","journal-title":"Curr Rheumatol Rep"},{"issue":"8","key":"1399_CR6","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.1093\/rheumatology\/keac722","volume":"62","author":"D Michailidou","year":"2023","unstructured":"Michailidou D, Johansson L, Kuley R et al (2023) Immune complex-mediated neutrophil activation in patients with polymyalgia rheumatica. Rheumatology (Oxford) 62(8):2880\u20132886. https:\/\/doi.org\/10.1093\/rheumatology\/keac722","journal-title":"Rheumatology (Oxford)"},{"key":"1399_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ard.2025.09.005","author":"EH Choy","year":"2025","unstructured":"Choy EH, Unizony SH, Wells AF et al (2025) Understanding the immunopathophysiology of polymyalgia rheumatica: implications for treatment. Ann Rheum Dis. https:\/\/doi.org\/10.1016\/j.ard.2025.09.005. (Epub ahead of print)","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1399_CR8","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s10067-023-06708-3","volume":"43","author":"I Coskun Benlidayi","year":"2024","unstructured":"Coskun Benlidayi I (2024) Why is polymyalgia rheumatica a disease of older adults? Explanations through etiology and pathogenesis: a narrative review. Clin Rheumatol 43(3):851\u2013861. https:\/\/doi.org\/10.1007\/s10067-023-06708-3","journal-title":"Clin Rheumatol"},{"issue":"4","key":"1399_CR9","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1136\/annrheumdis-2011-200329","volume":"71","author":"B Dasgupta","year":"2012","unstructured":"Dasgupta B, Cimmino MA, Maradit-Kremers H et al (2012) 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative. Ann Rheum Dis 71(4):484\u2013492. https:\/\/doi.org\/10.1136\/annrheumdis-2011-200329","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"1399_CR10","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1177\/0091270003258651","volume":"43","author":"DE Mager","year":"2003","unstructured":"Mager DE, Lin SX, Blum RA, Lates CD, Jusko WJ (2003) Dose equivalency evaluation of major corticosteroids: pharmacokinetics and cell trafficking and cortisol dynamics. J Clin Pharmacol 43(11):1216\u20131227. https:\/\/doi.org\/10.1177\/0091270003258651","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"1399_CR11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.80880","volume":"17","author":"A Muhammad","year":"2025","unstructured":"Muhammad A, Kakar ZH, Farooq M, Roohani MU, Bibi Z, Elgorashi K, Ahmad S, Ali J, Sami N (2025) Polymyalgia rheumatica and giant cell arteritis: a geriatric perspective. Cureus 17(3):e80880. https:\/\/doi.org\/10.7759\/cureus.80880","journal-title":"Cureus"},{"key":"1399_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01960","volume":"8","author":"T Fulop","year":"2018","unstructured":"Fulop T, Larbi A, Dupuis G et al (2018) Immunosenescence and inflamm-aging as two sides of the same coin: friends or foes? Front Immunol 8:1960. https:\/\/doi.org\/10.3389\/fimmu.2017.01960","journal-title":"Front Immunol"},{"issue":"1","key":"1399_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/10253890500100240","volume":"8","author":"ME Bauer","year":"2005","unstructured":"Bauer ME (2005) Stress, glucocorticoids and ageing of the immune system. Stress 8(1):69\u201383. https:\/\/doi.org\/10.1080\/10253890500100240","journal-title":"Stress"},{"issue":"4","key":"1399_CR14","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/acel.12222","volume":"13","author":"J Hazeldine","year":"2014","unstructured":"Hazeldine J, Harris P, Chapple IL et al (2014) Impaired neutrophil extracellular trap formation: a novel defect in the innate immune system of aged individuals. Aging Cell 13(4):690\u2013698. https:\/\/doi.org\/10.1111\/acel.12222","journal-title":"Aging Cell"},{"issue":"1","key":"1399_CR15","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/imr.13153","volume":"314","author":"K Van Avondt","year":"2023","unstructured":"Van Avondt K, Strecker JK, Tulotta C et al (2023) Neutrophils in aging and aging-related pathologies. Immunol Rev 314(1):357\u2013375. https:\/\/doi.org\/10.1111\/imr.13153","journal-title":"Immunol Rev"},{"issue":"1","key":"1399_CR16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/1756-185X.14000","volume":"24","author":"CE Owen","year":"2021","unstructured":"Owen CE, McMaster C, Liew DFL et al (2021) Neutrophil to lymphocyte ratio predicts glucocorticoid resistance in polymyalgia rheumatica. Int J Rheum Dis 24(1):56\u201362. https:\/\/doi.org\/10.1111\/1756-185X.14000","journal-title":"Int J Rheum Dis"},{"issue":"9","key":"1399_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23000","volume":"33","author":"JY Jung","year":"2019","unstructured":"Jung JY, Lee E, Suh CH, Kim HA (2019) Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are associated with disease activity in polymyalgia rheumatica. J Clin Lab Anal 33(9):e23000. https:\/\/doi.org\/10.1002\/jcla.23000","journal-title":"J Clin Lab Anal"},{"key":"1399_CR18","doi-asserted-by":"publisher","first-page":"15657","DOI":"10.2147\/JIR.S558175","volume":"18","author":"P Harkins","year":"2025","unstructured":"Harkins P, Cowley S, Conway R (2025) Current insights and future perspectives for the use of serological biomarkers in polymyalgia rheumatica. J Inflamm Res 18:15657\u201315670. https:\/\/doi.org\/10.2147\/JIR.S558175","journal-title":"J Inflamm Res"},{"issue":"11","key":"1399_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare13111226","volume":"13","author":"P Falsetti","year":"2025","unstructured":"Falsetti P, Manzo C, Isetta M et al (2025) Are there definite disease subsets in polymyalgia rheumatica? Suggestions from a narrative review. Healthcare 13(11):1226. https:\/\/doi.org\/10.3390\/healthcare13111226","journal-title":"Healthcare"},{"issue":"10","key":"1399_CR20","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1002\/art.24459","volume":"61","author":"MA Gonzalez-Gay","year":"2009","unstructured":"Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ et al (2009) Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum 61(10):1454\u20131461. https:\/\/doi.org\/10.1002\/art.24459","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1399_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rkac034","volume":"6","author":"S Muller","year":"2022","unstructured":"Muller S, Hider SL, Singh Sokhal B et al (2022) Long-term use of glucocorticoids for polymyalgia rheumatica: follow-up of the PMR cohort study. Rheumatol Adv Pract 6(2):rkac034. https:\/\/doi.org\/10.1093\/rap\/rkac034","journal-title":"Rheumatol Adv Pract"},{"issue":"1","key":"1399_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-12-94","volume":"12","author":"MA Cimmino","year":"2011","unstructured":"Cimmino MA, Parodi M, Montecucco C, Caporali R (2011) The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity. BMC Musculoskelet Disord 12(1):94. https:\/\/doi.org\/10.1186\/1471-2474-12-94","journal-title":"BMC Musculoskelet Disord"},{"issue":"2","key":"1399_CR23","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1080\/14397595.2020.1777680","volume":"31","author":"A Aoki","year":"2021","unstructured":"Aoki A, Kobayashi H, Yamaguchi Y (2021) Predictors of long-term therapy with glucocorticoid in polymyalgia rheumatica. Mod Rheumatol 31(2):417\u2013420. https:\/\/doi.org\/10.1080\/14397595.2020.1777680","journal-title":"Mod Rheumatol"},{"issue":"3","key":"1399_CR24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s40262-024-01466-0","volume":"64","author":"NN Ngcobo","year":"2025","unstructured":"Ngcobo NN (2025) Influence of ageing on the pharmacodynamics and pharmacokinetics of chronically administered medicines in geriatric patients: a review. Clin Pharmacokinet 64(3):335\u2013367. https:\/\/doi.org\/10.1007\/s40262-024-01466-0","journal-title":"Clin Pharmacokinet"},{"issue":"10","key":"1399_CR25","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1111\/bcp.14094","volume":"86","author":"AC van Drenth- Maanen","year":"2020","unstructured":"van Drenth- Maanen AC, Wilting I, Jansen PAF (2020) Prescribing medicines to older people-how to consider the impact of ageing on human organ and body functions. Br J Clin Pharmacol 86(10):1921\u20131930. https:\/\/doi.org\/10.1111\/bcp.14094","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"1399_CR26","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1093\/rheumatology\/kep303a","volume":"49","author":"B Dasgupta","year":"2010","unstructured":"Dasgupta B, Borg FA, Hassan N et al (2010) BSR and BHPR Standards, Guidelines and Audit Working Group. BSR and BHPR guidelines for the management of polymyalgia rheumatica. Rheumatology (Oxford) 49(1):186\u2013190. https:\/\/doi.org\/10.1093\/rheumatology\/kep303a","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"1399_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.70106","volume":"28","author":"M Sharma","year":"2025","unstructured":"Sharma M, Das SK, Mohindra R, Dutta D (2025) Efficacy and safety of tocilizumab in polymyalgia rheumatica: a systematic review and meta-analysis. Int J Rheum Dis 28(2):e70106. https:\/\/doi.org\/10.1111\/1756-185X.70106","journal-title":"Int J Rheum Dis"},{"issue":"4","key":"1399_CR28","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/acr.23320","volume":"70","author":"I Shbeeb","year":"2018","unstructured":"Shbeeb I, Challah D, Raheel S et al (2018) Comparable rates of glucocorticoid-associated adverse events in patients with polymyalgia rheumatica and comorbidities in the general population. Arthritis Care Res (Hoboken) 70(4):643\u2013647. https:\/\/doi.org\/10.1002\/acr.23320","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"1399_CR29","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3899\/jrheum.110851","volume":"39","author":"M Mazzantini","year":"2012","unstructured":"Mazzantini M, Torre C, Miccoli M et al (2012) Adverse events during longterm low-dose glucocorticoid treatment of polymyalgia rheumatica: a retrospective study. J Rheumatol 39(3):552\u2013557. https:\/\/doi.org\/10.3899\/jrheum.110851","journal-title":"J Rheumatol"},{"issue":"12","key":"1399_CR30","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1136\/ard.2008.100008","volume":"68","author":"JN Hoes","year":"2009","unstructured":"Hoes JN, Jacobs JW, Verstappen SM et al (2009) Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis. Ann Rheum Dis 68(12):1833\u20131838. https:\/\/doi.org\/10.1136\/ard.2008.100008","journal-title":"Ann Rheum Dis"}],"container-title":["European Geriatric Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-025-01399-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41999-025-01399-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-025-01399-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T08:02:09Z","timestamp":1777017729000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41999-025-01399-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["1399"],"URL":"https:\/\/doi.org\/10.1007\/s41999-025-01399-2","relation":{},"ISSN":["1878-7657"],"issn-type":[{"value":"1878-7657","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SO and MET declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Ethics Committee of Kartal Dr. L\u00fctfi K\u0131rdar City Hospital (Approval Date: 30.10.2023; Approval No: 2023\/514\/260\/34).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}